EFFICACY OF ULTRASOUND GUIDED PERIPHERAL NERVE BLOCKS IN TRIGEMINAL NEURALGIA PATIENTS RECEIVING COMBINATION DRUG THERAPY
Main Article Content
Keywords
Trigeminal neuralgia, ultrasound-guided nerve block, maxillofacial pain, neurovascular compression, pharmacotherapy, multimodal management, nerve block, pain relief, facial neuralgia, minimally invasive therapy
Abstract
Neuralgia involves pain along a damaged nerve, often resulting from injury or underlying pathology. Maxillofacial pain—originating from structures such as meninges, cornea, pulp, mucosa, and TMJ—comprises various neurological disorders that significantly impact patients' quality of life. Trigeminal neuralgia (TN), characterized by sudden, severe, shock-like facial pain, is among the most intense and common facial pain disorders. Diagnosis is primarily clinical, with neurovascular compression as a key etiology. Current treatments include pharmacotherapy, nerve blocks, and surgical procedures, but limitations such as adverse effects and procedural risks necessitate alternative approaches. Ultrasound-guided nerve blocks, combined with multi-drug regimens, present a minimally invasive option with potential benefits.
Objective: To evaluate the efficacy of ultrasound-guided peripheral nerve blocks combined with pharmacological therapy in patients with TN, focusing on pain reduction measured by the Numeric Rating Scale (NRS), safety, and patient satisfaction.
Methods: This prospective observational study included 33 patients with clinically diagnosed TN. All received a standardized three-drug regimen (carbamazepine, amitriptyline, baclofen) for 15 days, followed by ultrasound-guided nerve blocks targeting trigeminal divisions. Pain intensity was assessed at baseline, 15, and 30 days. Data analysis involved comparison of NRS scores and satisfaction levels.
Results: Significant reductions in NRS scores were observed in both groups, with a greater decrease in the nerve block group (from 7.75 to 1.25) versus the drug-only group (from 6.24 to 1.76) at 30 days (p<0.001). The percent change in pain was also significantly higher in the nerve block group. No major adverse effects were reported, and patient satisfaction was comparable.
Conclusion: Ultrasound-guided trigeminal nerve blocks, combined with multi-drug therapy, are effective and safe in managing TN pain. This multimodal strategy offers an advantageous alternative or adjunct to conventional treatments, potentially improving patient outcomes and reducing reliance on systemic medications.
References
2. Hargreaves KM. Orofacial pain. Pain. 2011 Mar;152(3 Suppl):S25-S32. doi: 10.1016/j.pain.2010.12.024. Epub 2011 Feb 2. PMID: 21292394; PMCID: PMC3077822.
3. Gilron I, Booher SL, Rowan MS, Smoller MS, Max MB. A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias. Neurology. 2000 Oct 10;55(7):964-71. doi: 10.1212/wnl.55.7.964. PMID: 11061252.
4. Siqueira JTT de, Teixeira MJ. Dor orofacial: diagnóstico, terapêutica e qualidade de vida. [cited 2025 Oct 8].
5. Cascone P, Fatone FMG, Paparo F, Arangio P, Iannetti G. Trigeminal impingement syndrome: The relationship between atypical trigeminal symptoms and antero-medial disk displacement. Cranio. 2010;28(3):177-80.
6. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292(19):2388-95.
7. Benoliel R, Birman N, Eliav E, Sharav Y. The International Classification of Headache Disorders: Accurate diagnosis of orofacial pain. Cephalalgia. 2008;28(7):752-62.
8. Tesseroli De Siqueira JT, Ching LH, Nasri C, et al. Clinical study of patients with persistent orofacial pain. Arq Neuro-Psiquiatr. 2004;62(4):988-96.
9. Peñarrocha M, Mora E, Bagán JV, García B, Peñarrocha M. Idiopathic Trigeminal Neuropathies: A presentation of 15 cases. J Oral Maxillofac Surg. 2009;67(11):2364-8.
10. Hegarty AM, Zakrzewska JM. Differential diagnosis for orofacial pain, including sinusitis, TMD, trigeminal neuralgia. Dent Update. 2011;38(6):396-400.
11. Jannetta PJ. Arterial compression of the trigeminal nerve at the pons in patients with trigeminal neuralgia. J Neurosurg. 2007;107(1):216-9. (Original work published 1967)
12. Crooks DA, Miles JB. Trigeminal neuralgia due to vascular compression in multiple sclerosis - Post-mortem findings. Br J Neurosurg. 1996;10(1):85-8.
13. Toda K. Etiology of Trigeminal Neuralgia. Oral Sci Int. 2007;4(1):10-8.
14. American Academy of Orofacial Pain. The scope of TMD/orofacial pain (head and neck pain management) in contemporary dental practice. Dental Practice Act Committee of the American Academy of Orofacial Pain. J Orofac Pain 1997;11(1):78-83.
15. Okeson, Jeffrey P, and Welden E Bell. Bell’s Orofacial Pains. 5th ed. Chicago: Quintessence Pub. Co., 1995. Print.
16. Katusic S, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol. 1990 Jan;27(1):89-95. doi: 10.1002/ana.410270114. PMID: 2301931.
17. Mueller D, Obermann M, Yoon MS, Poitz F, Hansen N, Slomke MA, Dommes P, Gizewski E, Diener HC, Katsarava Z. Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia. 2011 Nov;31(15):1542-8. doi: 10.1177/0333 102411424619. Epub 2011 Sep 29. PMID: 21960648.
18. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain. 2000 Apr;123 ( Pt 4):665-76. doi: 10.1093/brain/123.4.665. PMID: 10733998.
19. Sjaastad O and Bakketeig LS. The rare, unilateral headaches. Vaga study of headache epidemiology. J Headache Pain 2007;8:19-27.
20. Maarbjerg S, Gozalov A, Olesen J, Bendtsen L. Trigeminal neuralgia--a prospective systematic study of clinical characteristics in 158 patients. Headache. 2014 Nov-Dec;54(10):1574-82. doi: 10.1111/head.12441.
21. Wang QP, Bai M. Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia: A meta-analysis. CNS Drugs 2011; 25:847-57.
22. Fashner J, Bell AL. Herpes zoster and postherpetic neuralgia: Prevention and management. Am Fam Physician 2011; 83:1432-7.
23. Spatz AL, Zakrzewska JM, Kay EJ. Decision analysis of medical and surgical treatments for trigeminal neuralgia: How patient evaluations of benefits and risks affect the utility of treatment decisions. Pain 2007; 131:302-10.
24. Graif M, Seton A, Nerubai J, Horoszowski H, Itzchak Y. Sciatic nerve: sonographic evaluation and anatomic-pathologic considerations. Radiology. 1991 Nov;181(2):405-8. doi: 10.1148/radiology.181.2.1924780.
25. Marhofer P, Schrögendorfer K, Koinig H, Kapral S, Weinstabl C, Mayer N. Ultrasonographic guidance improves sensory block and onset time of three-in-one blocks. Anesth Analg. 1997 Oct;85(4):854-7. doi: 10.1097/00000539-199710000-00026. PMID: 9322469.
26. Chan VWS, Perlas A, Rawson R, Odukoya O. Ultrasound-guided supraclavicular brachial plexus block. Anesth Analg. 2003 Nov;97(5):1514-1517. doi: 10.1213/01.ANE.00000 62519.61520.14. PMID: 14570677.
27. Bangash T H. Trigeminal Neuralgia: Frequency of Occurrence in Different Nerve Branches.Anesth Pain Med.2011;1(2):70-72.https://doi.org/10.5812/kowsar.22287523.2164.
28. Katheriya G, Chaurasia A, Khan N, Iqbal J. Prevalence of trigeminal neuralgia in Indian population visiting a higher dental care center in North India. Natl J Maxillofac Surg 2019;10:195-9.
29. Gallay MN, Moser D, Jeanmonod D. MR-Guided Focused Ultrasound Central Lateral Thalamotomy for Trigeminal Neuralgia. Single Center Experience. Front Neurol. 2020 Apr 17; 11:271.
30. Han KR, Chae YJ, Lee JD, Kim C. Trigeminal nerve block with alcohol for medically intractable classic trigeminal neuralgia: long-term clinical effectiveness on pain. Int J Med Sci. 2017;14(1):29-36.
31. Ariyawardana A, Pallegama R, Sitheeque M, Ranasinghe A. Use of single- and multi-drug regimens in the management of classic (idiopathic) trigeminal neuralgia: an 11-year experience at a single Sri Lankan institution. J Investig Clin Dent. 2012 May;3(2):98-102.
32. Gerken JD, Fritzsche T, Denke C, Schäfer M, Tafelski S. Retrospective Study on Ganglionic and Nerve Block Series as Therapeutic Option for Chronic Pain Patients with Refractory Neuropathic Pain. Pain Res Manag. 2020 Jul 25;2020:6042941.
33. Nader A, Kendall MC, De Oliveria GS, Chen JQ, Vanderby B, Rosenow JM, Bendok BR. Ultrasound-guided trigeminal nerve block via the pterygopalatine fossa: an effective treatment for trigeminal neuralgia and atypical facial pain. Pain Physician. 2013 Sep-Oct;16(5):E537-45
